softgel capsules market
Pharmaceuticals

What Will The Softgel Capsules Market Look Like In 2023?

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s softgel capsules market report forecasts the softgel capsules market size to grow to $10.27 Billion by 2027, with a CAGR (compound annual growth rate) of more than 7%.

Learn More On The Softgel Capsules Market Report 2023 – https://www.thebusinessresearchcompany.com/report/softgel-capsules-global-market-report

Softgel Capsules Market Size Forecast
The global softgel capsules market is expected to grow from $7.20 billion in 2022 to $7.75 billion in 2023 at a compound annual growth rate (CAGR) of 7.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The softgel capsules market is expected to grow to $10.27 billion in 2027 at a CAGR of 7.3%.

North America held the largest softgel capsules market share.

Key Softgel Capsules Market Driver ­– Rise In The Prevalence Of Chronic Ailments Such As Cardiovascular Diseases
For instance, in September 2020, according to a study report issued by the American Action Forum, chronic illness frequency and expenses are increasing in the United States. Chronic illness is anticipated to continue increasing as the incidence of illness among children and young people increases. Chronic illness is a significant healthcare issue since it costs the US $3.7 trillion annually, or about 19.6% of the GDP, and is rising. Therefore, the rising prevalence of chronic ailments such as cardiovascular diseases will drive the soft gel capsules market.

Request for A Sample Of The Global Softgel Capsules Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8309&type=smp

Key Softgel Capsules Market Trend – Technological Advancement
Major companies operating in the soft gel capsules market are focused on developing new products with the latest technologies to sustain their position in the market. For instance, in November 2020, Roquette, a France-based provider of plant-based ingredients and pharmaceutical excipients, launched the pharmaceutical-grade solution LYCAGEL for a vegetarian soft gel capsule formulation developed with a pea starch technology. The new capsule formulation contains salt, NEOSORB sorbitol, a plant-based component utilized for nutraceutical purposes, and carrageenan, a setting agent found in marine macroalgae. The new product offers notable capsule strength, seal integrity, a short drying time without stickiness, quick disintegration, no cross-linking, and a processing temperature suitable for higher temperatures.

Softgel Capsules Market Segment
1) By Type: Gelatin or Animal Based, Non-Animal Based
2) By Manufacturers: Pharmaceutical Companies, Nutraceutical Companies, Cosmetic Companies, Contract Manufacturing Organizations, Softgel Capsules
3) By Application: Antacid And Anti-Flatulent Preparations, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic And Antibacterial Drugs, Cough And Cold Preparations, Health Supplement, Vitamin And Dietary Supplement, Pregnancy

Softgel Capsules Market Major Players and Strategies
Major players in the softgel capsules market are Catalent Inc., Eurocaps Ltd., Capsugel Healthcare Ltd., Aenova Group GmbH, Sirio Pharma Co. Ltd. (SIRIO), Procaps Laboratories, Captek Softgel International Inc., Fuji Capsule Co. Ltd., Hunan ER-KANG Pharmaceutical Co. Ltd., Patheon, Curtis Health Caps, Delpharm Evreux, Estrellas Life Sciences Pvt. Ltd., Elnova Pharma, and Soft Gel Technologies Inc.

In August 2021, Catalent, Inc., a US-based provider of development sciences and manufacturer of medicines, acquired Bettera Holdings, LLC, for $1 billion. Through this acquisition, Catalent, Inc. expects to accelerate the growth of its global softgel and oral dose formulation and manufacturing businesses to provide consumer health innovators with unrivalled choice, formulation expertise, and high-quality, scalable manufacturing solutions to help bring new products to market. Bettera Holdings LLC is a US-based provider of consumer-preferred products for nutraceutical, functional, and botanical ingredients, including soft gel capsules.

The Softgel Capsules Global Market Report 2023 covers regional data on softgel capsules market size, softgel capsules market trends and drivers, opportunities, strategies, and softgel capsules market competitor analysis. The countries covered in the softgel capsules market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Soft gelatin capsules, also known as softgels or soft elastic capsules, are capsules that dissolve faster than hard gelatin capsules and are used to carry medicine in liquid or powder form. It is used to deliver pharmaceuticals and a variety of nutritional supplements, including omega-3 fish oils.

View More Reports Related To The Softgel Capsules Market –
Multivitamin Capsules And Tablets Global Market Report 2023
Tablets Global Market Report 2023
Drug Delivery Devices Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas
+1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: